Article info
Extended reports
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
- Correspondence to:
Dr S B Cohen
Department of Rheumatology, St Paul Medical Center, 5939 Harry Hines Blvd, Suite 400, Dallas, TX 75235, USA; stanleycohenradiantresearch.net
Citation
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
Publication history
- Accepted February 19, 2004
- First published April 13, 2004.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Copyright information
Copyright 2004 by Annals of the Rheumatic Diseases